BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8832984)

  • 21. The risk of pediatric cardiovascular diseases in offspring born to mothers with systemic lupus erythematosus: a nationwide study.
    Cha JH; Hwang JK; Choi YJ; Na JY
    Front Pediatr; 2023; 11():1294823. PubMed ID: 38125818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Anti-Ro/SSA and Anti-La/SSB Autoantibodies With Pregnancy Outcome in the General Population.
    Dragoutsos G; Tsiggalou C; Oikonomou E; Bothou A; Trypsiannis G; Nikolettos K; Damaskos C; Garmpis N; Kyriakou D; Nalbanti T; Iatrakis G; Nikolettos N; Tsikouras P
    Mater Sociomed; 2024; 36(1):47-53. PubMed ID: 38590603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-synthetase syndrome and the risk of progressive pulmonary fibrosis: weighting of concomitant anti-Ro/SSA antibodies.
    Bernal-Bello D; Rodríguez-Rodríguez J; Duarte-Millán MÁ; Frutos-Pérez B
    Clin Rheumatol; 2023 Aug; 42(8):2249-2250. PubMed ID: 37183228
    [No Abstract]   [Full Text] [Related]  

  • 24. Home monitoring of fetal heart rhythm: Lived experiences of women with anti-SSA/Ro52 autoantibodies and their co-parents.
    Tingström J; Öst E; Bergman G; Burström Å
    Lupus; 2024 Apr; ():9612033241244465. PubMed ID: 38571373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Commentary: First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry).
    Costedoat-Chalumeau N; Morel N
    Front Cardiovasc Med; 2020; 7():83. PubMed ID: 32457919
    [No Abstract]   [Full Text] [Related]  

  • 26. Glycoxidation of mammalian whole histone generates highly immunogenic aggregates: Sera of SLE patients contain autoantibodies against aggregates.
    Islam SN; Arif Z; Badar A; Moinuddin ; Khan MA; Alam K
    Scand J Immunol; 2024 May; ():e13389. PubMed ID: 38816907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reply.
    Buyon J; Izmirly P; Masson M; Carlucci P; Izmirly CG; Clancy R; Cuneo B
    Arthritis Rheumatol; 2024 Jun; 76(6):986-987. PubMed ID: 38233972
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis.
    Gkoutzourelas A; Liaskos C; Mytilinaiou MG; Simopoulou T; Katsiari C; Tsirogianni A; Daoussis D; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
    Front Immunol; 2018; 9():2835. PubMed ID: 30581434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and pathological roles of Ro/SSA autoantibody system.
    Yoshimi R; Ueda A; Ozato K; Ishigatsubo Y
    Clin Dev Immunol; 2012; 2012():606195. PubMed ID: 23304190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block.
    Strandberg L; Winqvist O; Sonesson SE; Mohseni S; Salomonsson S; Bremme K; Buyon JP; Julkunen H; Wahren-Herlenius M
    Clin Exp Immunol; 2008 Oct; 154(1):30-7. PubMed ID: 18727629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interstitial lung disease and Sjögren's syndrome in primary biliary cirrhosis: a causal or casual association?
    Liu B; Zhang FC; Zhang ZL; Zhang W; Gao LX
    Clin Rheumatol; 2008 Oct; 27(10):1299-306. PubMed ID: 18512115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sjögren's syndrome--study of autoantigens and autoantibodies.
    Routsias JG; Tzioufas AG
    Clin Rev Allergy Immunol; 2007 Jun; 32(3):238-51. PubMed ID: 17992591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity of the anti-Ro(SSA) response in rheumatic diseases.
    López-Longo FJ; Rodríguez-Mahou M; Escalona M; Pérez T; Monteagudo I; Sánchez-Atrio A; Grau R; González C; Moreno AC; Carreño L
    J Rheumatol; 1994 Aug; 21(8):1450-6. PubMed ID: 7983645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
    Meyer O
    Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
    Clancy RM; Buyon JP; Ikeda K; Nozawa K; Argyle DA; Friedman DM; Chan EK
    Arthritis Rheum; 2005 Oct; 52(10):3079-86. PubMed ID: 16200587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antinuclear antibodies: clinical correlations and biologic significance.
    Sontheimer RD; McCauliffe DP; Zappi E; Targoff I
    Adv Dermatol; 1992; 7():3-52; discussion 53. PubMed ID: 1371222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
    Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
    J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study.
    Julkunen H; Miettinen A; Walle TK; Chan EK; Eronen M
    J Rheumatol; 2004 Jan; 31(1):183-9. PubMed ID: 14705240
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.